Brain metastasis magnetic resonance imaging-based deep learning for predicting epidermal growth factor receptor (EGFR) mutation and subtypes in metastatic non-small cell lung cancer

被引:1
作者
Cao, Ran [1 ,2 ]
Fu, Langyuan [1 ]
Huang, Bo [3 ]
Liu, Yan [1 ]
Wang, Xiaoyu [4 ]
Liu, Jiani [4 ]
Wang, Haotian [4 ]
Jiang, Xiran [1 ]
Yang, Zhiguang [5 ]
Sha, Xianzheng [1 ]
Zhao, Nannan [4 ]
机构
[1] China Med Univ, Sch Intelligent Med, 77 Puhe Rd, Shenyang 110122, Peoples R China
[2] Fudan Univ, Sch Informat Sci & Technol, Dept Biomed Engn, Shanghai, Peoples R China
[3] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Pathol, Shenyang, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Radiol, 44 Xiaoheyan Rd, Shenyang 110042, Peoples R China
[5] China Med Univ, Shengjing Hosp, Dept Radiol, 36 Sanhao St, Shenyang 110004, Peoples R China
基金
国家重点研发计划;
关键词
Brain metastases (BM); epidermal growth factor receptor (EGFR); EGFR ); deep learning; non-small cell lung cancer (NSCLC); radiomics; OPEN-LABEL; EXON; 19; MUTANT; SURVIVAL; RESISTANCE; BIOMARKER; 1ST-LINE; IMAGES;
D O I
10.21037/qims-23-1744
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The preoperative identification of epidermal growth factor receptor ( EGFR ) mutations and subtypes based on magnetic resonance imaging (MRI) of brain metastases (BM) is necessary facilitate individualized therapy. This study aimed to develop a deep learning model to preoperatively detect EGFR mutations and identify the location of EGFR mutations in patients with non-small cell lung cancer (NSCLC) and BM. Methods: We included 160 and 72 patients who underwent contrast-enhanced T1-weighted (T1w-CE) and T2-weighted (T2W) MRI at Liaoning Cancer Hospital and Institute (center 1) and Shengjing Hospital China Medical University (center 2) to form a training cohort and an external validation cohort, respectively. A multiscale feature fusion network (MSF-Net) was developed by adaptively integrating features based different stages of residual network (ResNet) 50 and by introducing channel and spatial attention modules. The external validation set from center 2 was used to assess the performance of MSF-Net and to compare it with that of handcrafted radiomics features. Receiver operating characteristic (ROC) curves, accuracy, precision, recall, and F1-score were used to evaluate the effectiveness of the models. Gradient-weighted class activation mapping (Grad-CAM) was used to demonstrate the attention of the MSF-Net model. Results: The developed MSF-Net generated a better diagnostic performance than did the handcrafted radiomics in terms of the microaveraged area under the curve (AUC) (MSF-Net: 0.91; radiomics: 0.80) and macroaveraged AUC (MSF-Net: 0.90; radiomics: 0.81) for predicting EGFR mutations and subtypes. Conclusions: This study provides an end-to-end and noninvasive imaging tool for the preoperative prediction of EGFR mutation status and subtypes based on BM, which may be helpful for facilitating individualized clinical treatment plans.
引用
收藏
页码:4749 / 4762
页数:14
相关论文
共 71 条
  • [1] Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
    Aerts, Hugo J. W. L.
    Velazquez, Emmanuel Rios
    Leijenaar, Ralph T. H.
    Parmar, Chintan
    Grossmann, Patrick
    Cavalho, Sara
    Bussink, Johan
    Monshouwer, Rene
    Haibe-Kains, Benjamin
    Rietveld, Derek
    Hoebers, Frank
    Rietbergen, Michelle M.
    Leemans, C. Rene
    Dekker, Andre
    Quackenbush, John
    Gillies, Robert J.
    Lambin, Philippe
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [2] Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases
    Ali, A.
    Goffin, J. R.
    Arnold, A.
    Ellis, P. M.
    [J]. CURRENT ONCOLOGY, 2013, 20 (04) : E300 - E306
  • [3] Machine and deep learning methods for radiomics
    Avanzo, Michele
    Wei, Lise
    Stancanello, Joseph
    Vallieres, Martin
    Rao, Arvind
    Morin, Olivier
    Mattonen, Sarah A.
    El Naqa, Issam
    [J]. MEDICAL PHYSICS, 2020, 47 (05) : E185 - E202
  • [4] Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study
    Cao, Ran
    Pang, Ziyan
    Wang, Xiaoyu
    Du, Zhe
    Chen, Huanhuan
    Liu, Jiani
    Yue, Zhibin
    Wang, Huan
    Luo, Yahong
    Jiang, Xiran
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2022, 67 (12)
  • [5] MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma
    Cao, Ran
    Dong, Yue
    Wang, Xiaoyu
    Ren, Meihong
    Wang, Xingling
    Zhao, Nannan
    Yu, Tao
    Zhang, Lu
    Luo, Yahong
    Cui, E-Nuo
    Jiang, Xiran
    [J]. ACADEMIC RADIOLOGY, 2022, 29 (03) : E9 - E17
  • [6] Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib
    Carey, Kendall D.
    Garton, Andrew J.
    Romero, Maria S.
    Kahler, Jennifer
    Thomson, Stuart
    Ross, Sarajane
    Park, Frances
    Haley, John D.
    Gibson, Neil
    Sliwkowski, Mark X.
    [J]. CANCER RESEARCH, 2006, 66 (16) : 8163 - 8171
  • [7] Mutations of the epidermal growth factor receptor in non-small cell lung cancer - Search and destroy
    Chan, SK
    Gullick, WJ
    Hill, ME
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (01) : 17 - 23
  • [8] Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer
    Chaudharyl, Kumardeep
    Poirionl, Olivier B.
    Lu, Liangqun
    Garmire, Lana X.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1248 - 1259
  • [9] Using stacked deep learning models based on PET/CT images and clinical data to predict EGFR mutations in lung cancer
    Chen, Song
    Han, Xiangjun
    Tian, Guangwei
    Cao, Yu
    Zheng, Xuting
    Li, Xuena
    Li, Yaming
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [10] Non-small-cell lung cancers: a heterogeneous set of diseases
    Chen, Zhao
    Fillmore, Christine M.
    Hammerman, Peter S.
    Kim, Carla F.
    Wong, Kwok-Kin
    [J]. NATURE REVIEWS CANCER, 2014, 14 (08) : 535 - 546